OMNICELL INC (OMCL) Stock Price, Forecast & Analysis

USA Nasdaq NASDAQ:OMCL • US68213N1090

45.32 USD
-3.38 (-6.94%)
Last: Feb 3, 2026, 02:28 PM

OMCL Key Statistics, Chart & Performance

Key Statistics
Market Cap2.03B
Revenue(TTM)1.18B
Net Income(TTM)19.92M
Shares44.88M
Float44.01M
52 Week High55
52 Week Low22.66
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)1.82
PE24.9
Fwd PE23.49
Earnings (Next)02-05
IPO2001-08-08
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
OMCL short term performance overview.The bars show the price performance of OMCL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40

OMCL long term performance overview.The bars show the price performance of OMCL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60 80

The current stock price of OMCL is 45.32 USD. In the past month the price increased by 7.89%. In the past year, price increased by 21.26%.

OMNICELL INC / OMCL Daily stock chart

OMCL Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to OMCL. When comparing the yearly performance of all stocks, OMCL is one of the better performing stocks in the market, outperforming 86.71% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OMCL Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to OMCL. Both the profitability and the financial health of OMCL get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OMCL Financial Highlights

Over the last trailing twelve months OMCL reported a non-GAAP Earnings per Share(EPS) of 1.82. The EPS increased by 27.27% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.69%
ROA 1.02%
ROE 1.63%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%-8.93%
Sales Q2Q%9.99%
EPS 1Y (TTM)27.27%
Revenue 1Y (TTM)10.67%

OMCL Forecast & Estimates

14 analysts have analysed OMCL and the average price target is 55.08 USD. This implies a price increase of 21.54% is expected in the next year compared to the current price of 45.32.

For the next year, analysts expect an EPS growth of 2.97% and a revenue growth 7.19% for OMCL


Analysts
Analysts77.14
Price Target55.08 (21.54%)
EPS Next Y2.97%
Revenue Next Year7.19%

OMCL Ownership

Ownership
Inst Owners103.21%
Ins Owners1.84%
Short Float %N/A
Short RatioN/A

OMCL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 21.1 189.00B
ISRG INTUITIVE SURGICAL INC 53.51 169.39B
SYK STRYKER CORP 26.48 138.02B
BSX BOSTON SCIENTIFIC CORP 30.9 135.12B
BDX BECTON DICKINSON AND CO 14.29 58.81B
IDXX IDEXX LABORATORIES INC 48.81 50.94B
EW EDWARDS LIFESCIENCES CORP 32 47.72B
RMD RESMED INC 24.47 36.73B
GEHC GE HEALTHCARE TECHNOLOGY 17.1 35.75B
DXCM DEXCOM INC 38.33 27.80B
PODD INSULET CORP 54.99 17.68B
ZBH ZIMMER BIOMET HOLDINGS INC 10.66 17.09B

Related stock screener links

About OMCL

Company Profile

OMCL logo image Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,600 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Company Info

OMNICELL INC

4220 North Freeway

Fort Worth TEXAS 94043 US

CEO: Randall A. Lipps

Employees: 3600

OMCL Company Website

OMCL Investor Relations

Phone: 18774159990

OMNICELL INC / OMCL FAQ

What does OMNICELL INC do?

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,600 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.


Can you provide the latest stock price for OMNICELL INC?

The current stock price of OMCL is 45.32 USD. The price decreased by -6.94% in the last trading session.


Does OMCL stock pay dividends?

OMCL does not pay a dividend.


How is the ChartMill rating for OMNICELL INC?

OMCL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Where is OMNICELL INC (OMCL) stock traded?

OMCL stock is listed on the Nasdaq exchange.